Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Regulatory Update - GSK and Valeant Respond to FDA on Ezogabine
Regulatory Update - GSK and Valeant Respond to FDA on Ezogabine
Regulatory Update - GSK and Valeant Respond to FDA on Ezogabine
Submitted by
admin
on April 23, 2011 - 11:06am
Source:
PharmaLive
News Tags:
GSK
Valeant Pharmaceuticals
ezogabine
epilepsy
Headline:
Regulatory Update - GSK and Valeant Respond to FDA on Ezogabine
Do Not Allow Advertisers to Use My Personal information
